Last reviewed · How we verify
recombinant Factor VIII — Competitive Intelligence Brief
phase 3
Biologic
Live · refreshed every 30 min
Target snapshot
recombinant Factor VIII (recombinant Factor VIII) — Octapharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| recombinant Factor VIII TARGET | recombinant Factor VIII | Octapharma | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- recombinant Factor VIII CI watch — RSS
- recombinant Factor VIII CI watch — Atom
- recombinant Factor VIII CI watch — JSON
- recombinant Factor VIII alone — RSS
Cite this brief
Drug Landscape (2026). recombinant Factor VIII — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-factor-viii. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab